ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Rheumatology

Top Rheumatology Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID OH M.D.

Rheumatology

31,283

$2.94M

1076
1017 are 65+

1%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 27%

$94
Average prescription price

Avg: $166

SEON WHANG

Rheumatology

20,535

$1.4M

647
591 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $166

SONWOO LEE MD

Rheumatology

18,855

$2.73M

608
584 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 27%

$145
Average prescription price

Avg: $166

DAVID LEHMAN M.D.

Rheumatology

16,320

$962K

539
452 are 65+

14%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $166

GILBERT GELFAND M.D.

Rheumatology

15,993

$3M

1299
1037 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$188
Average prescription price

Avg: $166

BIKRAMJIT AHLUWALIA MD

Rheumatology

13,654

$1.1M

746
480 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$81
Average prescription price

Avg: $166

SOLOMON FOROUZESH M.D.

Rheumatology

13,189

$2.41M

625
457 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 27%

$182
Average prescription price

Avg: $166

NICHOLAS KIM M.D.

Rheumatology

13,024

$1.71M

478
462 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 27%

$131
Average prescription price

Avg: $166

BRIAN HUH M.D.

Rheumatology

11,585

$3.51M

1013
911 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 27%

$303
Average prescription price

Avg: $166

THOMAS ROMANO M.D.

Rheumatology

11,319

$3.97M

836
625 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

64%
prescriptions for brand name drugs

Avg: 27%

$351
Average prescription price

Avg: $166

GERALD HO M.D.

Rheumatology

11,101

$1.82M

1234
943 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 27%

$164
Average prescription price

Avg: $166

MICHAEL KELLER M.D.

Rheumatology

10,508

$1.6M

1138
825 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$153
Average prescription price

Avg: $166

SAMY METYAS MD

Rheumatology

10,478

$2.21M

862
685 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 27%

$211
Average prescription price

Avg: $166

KENNETH WIESNER M.D.

Rheumatology

10,224

$1.12M

842
634 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$110
Average prescription price

Avg: $166

DAVID DANG M.D.

Rheumatology

9,994

$1.2M

566
475 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 27%

$120
Average prescription price

Avg: $166

ALLAN METZGER M.D.

Rheumatology

9,245

$905K

523
443 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 12%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 27%

$98
Average prescription price

Avg: $166

PURNELL KIRKLAND M.D.

Rheumatology

9,225

$1.16M

309
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 27%

$125
Average prescription price

Avg: $166

HOWARD HOOS MD

Rheumatology

9,044

$823K

477
389 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$91
Average prescription price

Avg: $166

AMIN ATTIA MD

Rheumatology

8,818

$567K

372
317 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $166

NOUNE PASHINIAN MD

Rheumatology

8,573

$2.2M

501
441 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 27%

$257
Average prescription price

Avg: $166

GLENN EHRESMANN M.D.

Rheumatology

8,416

$1.86M

320
218 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 27%

$221
Average prescription price

Avg: $166

WAGDY KADES M.D.

Rheumatology

8,301

$1.65M

836
706 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 27%

$198
Average prescription price

Avg: $166

NATHANIEL NEAL M.D.

Rheumatology

7,896

$1.55M

344
190 are 65+

28%
patients receiving schedule two controlled substances

Avg: 2%

29%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$197
Average prescription price

Avg: $166

KAREN SHAINSKY D.O.

Rheumatology

7,824

$1.22M

776
735 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 27%

$156
Average prescription price

Avg: $166

HERBERT FISHER M.D.

Rheumatology

7,566

$422K

441
394 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $166

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank